272 related articles for article (PubMed ID: 21210118)
1. GATA factors in gastrointestinal malignancy.
Ayanbule F; Belaguli NS; Berger DH
World J Surg; 2011 Aug; 35(8):1757-65. PubMed ID: 21210118
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.
Beilstein M; Silberg D
Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613
[TBL] [Abstract][Full Text] [Related]
4. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
6. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
8. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
9. Impact of homeobox genes in gastrointestinal cancer.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 Oct; 22(37):8247-8256. PubMed ID: 27729732
[TBL] [Abstract][Full Text] [Related]
10. Early Barrett's carcinoma of the esophagus.
Hölscher AH; Vallböhmer D; Bollschweiler E
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
[No Abstract] [Full Text] [Related]
11. [Carcinogenesis of Barrett's esophagus].
Endo T; Sugawara N; Shinomura Y
Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Smith CM; Watson DI; Michael MZ; Hussey DJ
World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019
[TBL] [Abstract][Full Text] [Related]
15. [Genome analyses for precancerous lesions in the gastrointestinal tract].
Sowa M; Nakata B
Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
[TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus: ordering the events that lead to cancer.
Reid BJ; Barrett MT; Galipeau PC; Sanchez CA; Neshat K; Cowan DS; Levine DS
Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():57-65. PubMed ID: 9061296
[No Abstract] [Full Text] [Related]
17. Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa.
Haveri H; Westerholm-Ormio M; Lindfors K; Mäki M; Savilahti E; Andersson LC; Heikinheimo M
BMC Gastroenterol; 2008 Apr; 8():9. PubMed ID: 18405344
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in malignant transformation of Barrett's esophagus.
Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
[TBL] [Abstract][Full Text] [Related]
19. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
Walch A; Mueller J; Höfler H; Werner M
J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093
[No Abstract] [Full Text] [Related]
20. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
